Ignite Creation Date:
2024-05-06 @ 3:24 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02282007
Status:
COMPLETED
Last Update Posted:
2022-10-06
First Post:
2014-03-17
Brief Title:
Norwegian Psychomotor Physiotherapy - The Effect on Quality of Life
Sponsor:
Oslo Metropolitan University
Organization:
Oslo Metropolitan University
Study Overview
Official Title:
Norwegian Psychomotor Physiotherapy - The Effect on Quality of Life The Feeling of Pain Coping Physical Psychological and Social Functioning After the Treatment
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
More and more people suffer from stress-related illness and ailments that can greatly affect the individuals experienced quality of life and sense of coping since pain physical mental and social functioning are closely linked Many of these people will seek primary care for help and thus be referred to the Norwegian psychomotor physiotherapy NPMP performed by physiotherapists in primary care
Data shows that for the first three months of 2009 42 of patients were referred to NPMP had a musculoskeletal diagnosis as the first diagnosis often in the form of long-term and comprehensive pain problems Many of the patients also had emotional difficulties but without being diagnosed with mental illness 23 of patients who were referred to NPMP had a psychiatric diagnosis as the first diagnosis The full range of psychiatric diagnoses are represented but the majority of patients were treated for anxiety and depression
The investigators want to let people who have had NPMP treatment to consider what effect the treatment has given measured by separate registrations of quality of life pain physical mental and social functioning
Data shows that for the first three months of 2009 42 of patients were referred to NPMP had a musculoskeletal diagnosis as the first diagnosis often in the form of long-term and comprehensive pain problems Many of the patients also had emotional difficulties but without being diagnosed with mental illness 23 of patients who were referred to NPMP had a psychiatric diagnosis as the first diagnosis The full range of psychiatric diagnoses are represented but the majority of patients were treated for anxiety and depression
The investigators want to let people who have had NPMP treatment to consider what effect the treatment has given measured by separate registrations of quality of life pain physical mental and social functioning
Detailed Description:
The primary aim of this is project intends to evaluate the effect of Norwegian psychomotor physiotherapy NPMP on Health related Quality of Life measured by Short-form Health Survey SF-36 The secondary aims are to evaluate the effect of Norwegian psychomotor physiotherapy NPMP on the variables Subjective Health Complaints Inventory SHC Hopkins s Symptom Check List Örebro Screening for musculo-skeletal pain Numeric Pain Rating Scale Oslo Social Support Scale Coping and The self-esteem scale
The study design is based on the guidelines for randomized controlled trials presented in the CONSORT statement The study will address to people who have had NPMP treatment approach and they will be asked to consider what effect the treatment has given measured by separate registrations of quality of life pain physical mental and social functioning
Participants Power calculation based on the primary outcome Short-form Health Survey SF-36 proved that minimum 170 participants must be recruited The participants will be recruited among patients on the waiting list for NPMP by all psychomotor physiotherapists who are members of the Norwegian Physiotherapists Association If patients want to participate in the study they will be randomized to an intervention group and a control group by drawing lots
The intervention group will have NPMP as usual in 6 months The control group remains on the waiting list for 6 months Participants in both groups will be asked to fill out the self-assessment questionnaire at the start of the project and at the completion of the project after six months Participants in the intervention group will receive the same form after 12 months to examine whether there have been any subsequent change after completion NPMF
Timing of surveys
Participants will be given questionnaires by the NPMP physiotherapist at
Baseline - 2 weeks before NPMF both groups
After 6 months both groups
After 12 months intervention group
The study design is based on the guidelines for randomized controlled trials presented in the CONSORT statement The study will address to people who have had NPMP treatment approach and they will be asked to consider what effect the treatment has given measured by separate registrations of quality of life pain physical mental and social functioning
Participants Power calculation based on the primary outcome Short-form Health Survey SF-36 proved that minimum 170 participants must be recruited The participants will be recruited among patients on the waiting list for NPMP by all psychomotor physiotherapists who are members of the Norwegian Physiotherapists Association If patients want to participate in the study they will be randomized to an intervention group and a control group by drawing lots
The intervention group will have NPMP as usual in 6 months The control group remains on the waiting list for 6 months Participants in both groups will be asked to fill out the self-assessment questionnaire at the start of the project and at the completion of the project after six months Participants in the intervention group will receive the same form after 12 months to examine whether there have been any subsequent change after completion NPMF
Timing of surveys
Participants will be given questionnaires by the NPMP physiotherapist at
Baseline - 2 weeks before NPMF both groups
After 6 months both groups
After 12 months intervention group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None